News | November 10, 2008

Philips' 16-Lead ECG Algorithm Technology May Help Diagnose Hidden Myocardial Infarction

November 11, 2008 - Royal Philips Electronics today unveiled a new PageWriter TC70 cardiograph technology to help improve detection and identification of problems in the heart, including specific coronary artery obstructions, damaged heart muscle and abnormal rhythms at the American Heart Association's Scientific Sessions 2008.

The PageWriter TC70, featuring Philips' DXL 16-lead ECG algorithm, may help clinicians deliver faster diagnosis and treatment during heart attacks, while also supporting door-to-balloon and hospital quality initiatives, the company said.

While limb and chest leads have been traditional components of the 12-lead ECG, it has long been recognized that additional electrodes can provide information that is poorly or not seen at all on a traditional 12-lead ECG. The standard 12-lead ECG has a blind spot on the right side of the patient's chest that limits the ability to detect right ventricular myocardial infarction (MI). Philips' new DXL algorithm technology addresses this issue by using electrodes placed on the right side to provide incremental capabilities not available with previous analysis programs.

"We're using right chest and posterior leads and see true patient benefits by diagnosing a hidden MI that we may not have picked up with a 12-lead ECG," said Debbie Heinecke, RN, manager of non-invasive cardiology at Blessing Hospital in Quincy, IL, an early user of the new technology.

According to the AHA, one in three female adults in the U.S. has some form of cardiovascular disease and all cardiovascular diseases combined claim the lives of more than 400,000 American women annually - greater than all forms of cancer combined. Women often present cardiac symptoms differently from men and have a higher mortality rate from cardiovascular disease.

Philips said the DXL algorithm applies new gender, age and lead-specific STEMI (ST-segment elevation myocardial infarction) criteria to detect acute MI in women as well as men. A widespread pattern of ST depression often reflects global ischemia due to left main coronary obstruction, multi-vessel obstructions, or microvascular disease, which is more prevalent in women. The DXL algorithm incorporates new criteria for these conditions and provides a Critical Value of "global ischemia" to highlight that prompt intervention may be needed. The new algorithm also builds upon Philips' use of gender and age-specific criteria left ventricular hypertrophy and prolonged QT interval.

The PageWriter TC70 cardiograph reportedly improves workflow and enables faster clinical decision making. The company said ECG reports are quickly taken and transferred to the TraceMasterVue ECG management system with the click of a button. Bedside decision-making is enhanced with the automatic retrieval of the previous ECG, allowing for immediate clinical serial comparison.

The new PageWriter TC70 includes technologies that are especially useful in the emergency department, where ECG reports can highlight test results that may warrant immediate clinical attention.

For more information: www.philips.com

Related Content

HeartSciences MyoVista ECG Device Shows Promise in Detecting Abnormal Cardiac Function
News | ECG | April 27, 2018
HeartSciences announced the results of a clinical study of its electrocardiography device that applies continuous...
ECG Study of NBA Players Shows Need for Sport-Specific Normative Data and Guidelines
News | ECG | December 08, 2017
Cardiologists at NewYork-Presbyterian/Columbia University Irving Medical Center compared electrocardiographic findings...
HeartSciences Announces CE Mark and European Launch of MyoVista High Sensitivity ECG

Just as a Doppler radar color image shows the energy of a storm, MyoVista provides physicians a detailed visual image of the energy distribution during the cardiac cycle.

News | ECG | August 22, 2017
HeartSciences announced the European launch of the MyoVista high sensitivity electrocardiograph (hsECG) Testing Device...
AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG | August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
More Than 20 Percent of Low-Risk Patients Receive Annual ECG
News | ECG | July 20, 2017
July 20, 2017 — More than one in five Ontario patients receive an ...
Heart Test Laboratories, HTL, MyoVista ECG, common stock offering
News | ECG | January 31, 2017
Heart Test Laboratories Inc. (HTL) has successfully raised $12 million by way of a Common Stock private placement...
AirStrip One, ECG management, web client, U.S. clearance
Technology | ECG | October 11, 2016
The U.S. Food and Drug Administration (FDA) has issued 510(K) Class II clearance to a web client for the AirStrip One...
Carestream, Vue Motion universal viewer, ECG waveforms, diagnostic reading, FDA clearance

Image courtesy of Carestream Health

Technology | ECG | November 20, 2015
Carestream has obtained U.S. Food and Drug Administration (FDA) clearance for diagnostic reading of electrocardiogram (...
CardioSecur mobile ECG, 22-lead, 360 degree view of the heart, CardioSecur Pro

Image courtesy of CardioSecur

Technology | ECG | October 08, 2015
Personal MedSystems introduced the first and only 22-lead mobile electrocardiogram (ECG) system, CardioSecur, at the...
Mortara, ELI 280, TouchScreen ECG, ECG advances, new ECG technology

The Mortara Eli 280 is part of a new generation of ECG systems that integrate touchscreen monitors to improve workflow.

Feature | ECG | September 16, 2015 | Dave Fornell
The resting electrocardiogram (ECG) has been us
Overlay Init